本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Pasithea Therapeutics Corp.

0.5300
-0.0100-1.85%
盤後0.53000.00000.00%17:25 EDT
成交量:14.11萬
成交額:7.50萬
市值:1,770.97萬
市盈率:-0.36
高:0.5515
開:0.5310
低:0.5202
收:0.5400
52周最高:2.06
52周最低:0.2810
股本:3,341.44萬
流通股本:1,020.20萬
量比:0.66
換手率:1.38%
股息:- -
股息率:- -
每股收益(TTM):-1.4820
每股收益(LYR):-2.9100
淨資產收益率:-65.49%
總資產收益率:-36.00%
市淨率:0.36
市盈率(LYR):-0.18

資料載入中...

2026/09/09

重要事件披露

Form 8-K - Current report
2026/08/21

重要事件披露

Form 8-K - Current report
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/31

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/01

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/23

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/22

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/08

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/31

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/20

重要事件披露

Form 8-K - Current report
2026/01/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/29

重要事件披露

Form 8-K - Current report
2025/12/15

重要事件披露

Form 8-K - Current report
2025/12/02

重要事件披露

Form 8-K - Current report
2025/11/27

SEC問詢函

Form CORRESP - Correspondence
2025/11/27

SEC問詢函

Form CORRESP - Correspondence